Characterization of inhibition of Mycobacterium avium replication in macrophages by normal human serum
- PMID: 1730466
- PMCID: PMC257634
- DOI: 10.1128/iai.60.2.345-352.1992
Characterization of inhibition of Mycobacterium avium replication in macrophages by normal human serum
Abstract
Serum from some AIDS patients permits the rapid multiplication of Mycobacterium avium in cultured human macrophages. Serum from human immunodeficiency virus-negative individuals inhibits replication. The characteristics of the serum-induced inhibition were examined here. M. avium 7497 serovar 4 grew exponentially in macrophages when they were cultured in serumless medium. Growth was measured by determining the CFU after infected macrophages were lysed at 0 to 7 days after infection. Normal AB serum (5 to 10%) added to infected macrophages resulted in an initial 4-day lag of bacterial growth followed by rapid replication from 4 to 7 days. Serum also inhibited bacterial replication in medium without macrophages. This inhibition was not biphasic but was sustained over 7 days. Macrophage-associated M. avium became less responsive to serum inhibitor within 24 h after infection of macrophages. Within 2 days of culture, M. avium no longer responded to inhibitor. Replication of macrophage-derived M. avium (Vi) was in some instances serum inhibitable and at other times was enhanced by serum, when it was used to infect fresh macrophages. The Vi phenotype remained serum inhibitable without macrophages. Preinfection of macrophages with heat-killed M. avium did not alter serum-induced bacterial inhibition or escape from inhibition.
Similar articles
-
Comparison of the abilities of Mycobacterium avium and Mycobacterium intracellulare to infect and multiply in cultured human macrophages from normal and human immunodeficiency virus-infected subjects.Infect Immun. 1992 Sep;60(9):3697-703. doi: 10.1128/iai.60.9.3697-3703.1992. Infect Immun. 1992. PMID: 1500179 Free PMC article.
-
Transferrin, iron, and serum lipids enhance or inhibit Mycobacterium avium replication in human macrophages.J Infect Dis. 1993 Apr;167(4):857-64. doi: 10.1093/infdis/167.4.857. J Infect Dis. 1993. PMID: 8450251
-
Effects on Mycobacterium avium replication in normal human macrophages by deferiprone (L1) and other iron chelators. Possible implications on toxicity.Arzneimittelforschung. 2002;52(1):45-52. doi: 10.1055/s-0031-1299855. Arzneimittelforschung. 2002. PMID: 11838274
-
Inhibition by normal human serum of Mycobacterium avium multiplication in cultured human macrophages.Infect Immun. 1989 Apr;57(4):1332-5. doi: 10.1128/iai.57.4.1332-1335.1989. Infect Immun. 1989. PMID: 2494117 Free PMC article.
-
Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages.Infect Immun. 1992 Jun;60(6):2453-8. doi: 10.1128/iai.60.6.2453-2458.1992. Infect Immun. 1992. PMID: 1587613 Free PMC article.
Cited by
-
Enhanced intramacrophage activity of resorcinomycin A against Mycobacterium avium-Mycobacterium intracellulare complex after liposome encapsulation.Antimicrob Agents Chemother. 1996 Nov;40(11):2545-9. doi: 10.1128/AAC.40.11.2545. Antimicrob Agents Chemother. 1996. PMID: 8913461 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources